DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Cardiovascular Devices Market Analysis By Product and Segment Forecasts To 2024" report to their offering.
Global cardiovascular devices market is anticipated to reach USD 121 billion by 2024, according to this new report. Increasing geriatric population, sedentary life style coupled with unhealthy dietary habits is spurring the prevalence of cardiovascular diseases.
Governments are trying to limit hospital readmissions to reduce the prevalence of hospital acquired infections (HAIs) by imposing penalties on hospitals. As a result, adoption of home healthcare, remote patient monitoring, and long term care services is rapidly increasing. Thus, demand for cardiovascular devices is increasing from hospitals, patients based in home settings, and long term care centers.
In addition, favorable government policies such as reimbursement coverage are fueling adoption of these devices. Thus, increasing target patient population, rising acceptance of home healthcare, and favorable government policies are some of the major factors driving the growth of the global cardiovascular devices market.
On the other hand, high device cost and stringent regulatory approval procedure are some of the prime factors challenging the growth of the market. In addition, lack of skilled professionals to perform surgical procedures using advanced devices is impeding the adoption of new devices.
- Medtronic plc
- Becton Dickinson and Company
- Cardinal Health, Inc.
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Abbott Laboratories, Inc.
- Cook Medical, Inc.
- Terumo Cardiovascular Systems Corporation
St. Jude Medical, Inc.
1 Executive Summary
2 Market Snapshot
3 Market Variables, Trends & Scope
4 Market Categorization 1: by product
5 Market Categorization 2: Regional Estimates & Trend Analysis, by Product
6 Competitive Landscape
For more information about this report visit http://www.researchandmarkets.com/research/rc5jgr/cardiovascular